We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Zynlonta
Australian Public Assessment Report
Device/Product Name
Zynlonta
Active ingredients
loncastuximab tesirine
AusPAR Date
Published
Sponsor
Submission Number
PM-2025-00489-1-4
Submission Type
New biological entity
Decision
Approved